Dahan Michel — SEC Form 4 filings

SEC reporting owner CIK 1669737. 4 Form 4 filings on record with FilingPulse; latest filed 2024-05-14.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-02 to 2024-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Akebia Therapeutics, Inc. (AKBA)SVP, Chief Operating Officer43 legs · 54,245 sh · $73,9142

Form 4 filings — Dahan Michel

FiledFormIssuerReported transactionsSource
2024-05-144Akebia Therapeutics, Inc. (AKBA)Sale (S): 34,840 @ $1.26EDGAR
2024-03-014Akebia Therapeutics, Inc. (AKBA)Sale (S): 8,661 @ $1.58EDGAR
2024-02-294Akebia Therapeutics, Inc. (AKBA)Sale (S): 10,744 @ $1.52EDGAR
2024-02-024Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 149,300 @ $0 · Grant/award (A): 224,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1669737 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →